The aim of this study was to investigate angiotensin II type 1 (AT1) receptors in rat bladder smooth muscle cells and alterations of AT1 receptors by diabetes mellitus and diuretic states. Materials and Methods: Diabetes and diuresis were induced in adult female rats by a single intraperitoneal injection of streptozotocin and feeding 5% sucrose in water. Cystometry was performed on control, diuretic, and diabetic rats at 2 and 8 weeks after treatment. Immunohistochemical staining was used to detect expression of AT1 receptors in the bladder smooth muscle cell membrane.
Introduction
Diabetes mellitus resulting as a long-term complication of the lower urinary tract is referred to as diabetic cystopathy [1] . Many factors probably contribute to the large capacity atonic bladder that characterizes diabetic cystopathy, including changes in the bladder smooth muscle [2] . Diuresis originating from diabetes mellitus causes increases in the bladder mass and changes contractility of the bladder strip [1, 2] .
Angiotensin II (AngII) is a potent vasoconstrictor and an integral part of the renin-angiotensin system (RAS), which regulates vascular tone, blood pressure, and sodium homeostasis. In addition to the systemic effects of this hormone, AngII may regulate cellular growth and function in several organ systems through a local RAS. In fact, there is increasing evidence suggesting that AngII is a local trophic factor in the wall of the bladder that is responsible for regulating smooth muscle cell growth under both normal and pathological conditions [3] . AngII may also play a role in the control of collagen production [4] .
Previous studies demonstrated that local RAS plays a role in the functional disorder and fibrosis of many organs, including the kidneys [5], heart [6], lungs [7] , and liver [8] . Moreover, the functional disorder and fibrosis caused by diabetes mellitus have been reported to be associated with a local RAS. However, to our knowledge, whether the RAS is associated with bladder dysfunction caused by diabetes mellitus has not been investigated. Therefore, in the present study, we investigated angiotensin II type 1 (AT1) receptors in rat detrusor muscle and alterations of AT1 receptors by diabetes mellitus and diuretic states.
Materials and Methods

Induction of Diabetes and Diuresis
Diabetes was induced in adult female Sprague-Dawley rats (weight 230-280 g; Hilltop Laboratory, Pittsburgh, PA) by a single intraperitoneal injection (65 mg/kg) of streptozotocin (STZ) dissolved in an ice-cold 0.1M citrate buffer. The blood glucose level of the rats was checked 1 week after STZ injection and rechecked before death to confirm the presence of diabetes (blood glucose > 300 mg/dl). Chronic diuresis was induced by feeding 5% sucrose in water. Normal rats were used as controls. The study protocol was approved by the Animal Ethics Committee at Nagasaki University Graduate School of Biochemical Sciences, Japan.
Cystometry
Cystometry was performed on control, diuretic, and diabetic rats at 2 and 8 weeks after treatment. The rats were anesthetized by intraperitoneal injection of 1 g/kg body weight urethane. A PE-50 catheter was inserted through the bladder apex into the lumen and then was connected to a pressure transducer and a microinjection pump (UD5500, Dantec, Denmark). Warmed saline was infused into the bladder at a rate of 10 ml/h for the control, diuretic, and diabetic rats.
Saline voided from the urethral meatus was collected and measured to determine the voided volume. After constant voided volumes were collected, the infusion was temporarily stopped and the post-void residual urine volume was measured by withdrawing intravesical fluid through the catheter, first by gravity and then by manually pressing the bladder. The bladder capacity was calculated as the sum of the voided volume and the volume of the post-void residual urine. The voiding efficiency was estimated as follows: voiding efficiency (%) = [(voided volume/bladder capacity) × 100]. The maximal voiding pressure was also measured.
Histological Evaluation
The bladder specimens of the control, diuretic and DM rats were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) and embedded in paraffin. Sections were deparaffinized with xylene, and sequentially rehydrated in a graded ethanol series (100, 95, 90, 80, and 70%) for 5 min each. The endogenous peroxidase activity was blocked by incubation in 3% H 2 O 2 in methanol for 15 min. The sections were blocked with 1% goat serum and 5% skim milk, and incubated at 4ºC for 24 hours with rabbit AT1 polyclonal antibody (Santa Cruz, California, USA) diluted 1:500 in PBS. After washing, the sections were incubated with Histofine Simple Stain Rat Max-PO (Nichirei Co., Tokyo, Japan) for 30 minutes at room temperature. The sections were stained with diaminobenzidine tetrahydrochloride (Nichirei Co., Tokyo, Japan), counterstained with hematoxylin and then mounted. The sections were also stained with Masson's trichrome staining to visualize the fibrosis of the bladder wall tissue.
Statistical Analysis
All data were expressed as means ± SD. Student's t-test was used for comparisons between the control, diuretic and diabetic rat groups. Statistical significance was accepted at a value of p < 0.05.
Results
General Characteristics
The body weight of the diuretic rats was significantly higher in comparison to that of control rats, and that of the diabetic rats was significantly decreased in comparison to that of control rats (table 1). The blood glucose levels Tobu/Noguchi/Hatada/Mori/Matsuo/Sakai of the diabetic rats were about 4 times higher than those of the control and diuretic rats. The bladder weights of the diuretic and diabetic rats were approximately twice those of the control rats.
Cystometry
Cystometry revealed that the mean bladder capacity and compliance increased in all treated rats compared with controls (table 1). Although diabetic rats had a significantly decreased voiding efficiency, the mean maximal voiding pressure was similar in all groups.
Histological Findings
Masson's trichrome staining revealed that the color of bladder smooth muscle cells changed from red to blue in 2 and 8 weeks after treatment in diabetic rats ( fig. 1, 2) . This suggests that contentious hyperglycemia induced the observed fibrotic change in the bladder wall.
Immunohistochemical staining was done to detect expression of AT1 receptors in the bladder smooth muscle cell membrane. AT1 receptors were sparsely expressed in the bladder smooth muscle cell membrane in control and diuretic rats. However, in diabetic rats, expression of AT1 receptors in the bladder smooth muscle cell membrane was increased at 2 weeks, and was further increased at 8 weeks.
Discussion
AngII within the rat bladder tissue has been rarely studied, and to the best of our knowledge, AngII within the bladder of a diabetic rat model has not been investigated. A previous report indicated that hyperglycemia caused by STZ strongly induced expression of AT receptors in the rat kidney [9] . Our results suggested that the same phenomenon occurs in rat bladder tissue. Harrison-Bernard et al. [9] reported that expression of plasma AngII is increased in STZ-induced diabetic rats in comparison to control rats, and that the RAS is activated in rat kidney tissue by continuous hyperglycemia. Our results suggested that the RAS could also be activated in rat bladder tissue by continuous hyperglycemia. The bladder weight was increased by diuresis compared to that of control rats, so that the STZ-induced hyperglycemia increased the rat bladder weight more than that of diuretic rats. These findings suggested that an increase in bladder weight could be induced by chronic mechanical stress to the rat bladder wall by diuresis, and that contentious hyperglycemia could further increase the rats' bladder weight.
Interestingly, the AT1 receptor was highly expressed in STZ-induced diabetic rat bladders, although expression of AT1 receptors of diuretic rats did not change in comparison to the control rats. This suggested that the activation of the RAS might occur in STZ-induced diabetic rat bladder tissue.
It is now accepted that blockade of the RAS can contribute to improving the pathogenesis of diabetic nephropathy, and angiotensin receptor blockers (ARBs) are now commonly used in clinical practice. It is unknown whether ARBs can improve the pathogenesis of diabetic cystopathy. However, the present findings indicate that an investigation of the potential of ARBs to prevent or treat diabetic cystopathy is warranted.
Conclusion
In this study, we demonstrated that expression of AT1 receptors was enhanced by severe hyperglycemia in a rat diabetic model. The local RAS in the rat bladder might be activated by the continuous hyperglycemia caused by STZ administration.
